Hims & Hers Health stock drops; DOJ probes weight-loss meds; lawsuit criticized

Key facts: Hims & Hers Health stock drops; DOJ probes weight-loss meds; lawsuit criticized — TradingView News

On February 9, 2026, Hims & Hers Health (HIMS) stock dropped to $17.83, a 22.55% decline from $23.02, prompting an intraday rebalance of related ETP Securities.1
The U.S. Department of Health has referred Hims & Hers Health to the Justice Department for a possible investigation into violations related to its weight-loss medications.2 3
Hims & Hers Health called a recent lawsuit a ‘blatant attack’ on Americans needing compounded medications, criticizing the pharma industry for using the courts to limit consumer choice.4

Hims & Hers Health stock drops; DOJ probes weight-loss meds; lawsuit criticized — TradingView News